» Articles » PMID: 36114481

Non-uptake of HIV Testing Among Trans Men and Trans Women: Cross-sectional Study of Client Records from 2017 to 2019 in a Community-based Transgender Health Center in Metro Manila, Philippines

Overview
Publisher Biomed Central
Specialty Public Health
Date 2022 Sep 16
PMID 36114481
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Transgender individuals are considered at high risk of contracting HIV infection. Integrating HIV testing and counseling (HTC) services into current transgender health programs is necessary to increase its uptake. Our study aimed to describe the characteristics of trans men (TM) and trans women (TW) who accessed HTC services in a community-based transgender health center in Metro Manila, Philippines, and to examine the relationship between gender identity and their non-uptake of HIV testing.  METHODS: We conducted a cross-sectional study of TM and TW seeking care from 2017 to 2019. Medical records of clients were reviewed to ascertain their age, gender identity, year and frequency of clinic visits, lifestyle factors, and non-uptake of HIV testing. The effect of gender identity on the non-uptake of HIV testing was estimated using a generalized linear model with Poisson distribution, log link function, and a robust variance, adjusted for confounding variables.  RESULTS: Five hundred twenty-five clients were included in the study, of which about 82.3% (432/525) of the clients declined the HTC services being offered. In addition, the prevalence of non-uptake of HIV testing was 48% higher (Adjusted Prevalence Ratio: 1.48; 95% Confidence Interval: 1.31-1.67) among TM compared to TW. Approximately 3.7% (1/27) and 10.6% (7/66) of the TM and TW, respectively, who accessed the HTC services were reactive. Moreover, most reactive clients were on treatment 87.5% (7/8); three were already virally suppressed, four were on ART but not yet virally suppressed, and one TW client was lost to follow up.

Conclusion: The non-uptake of HTC service of TM and TW is high. HIV program implementers should strategize solutions to reach this vulnerable population for increased and better HTC service uptake and linkage to care.

Citing Articles

Gender in Health: Addressing Transgender-Related Stigma and Health Disparities in Southeast Asia.

Alibudbud R Inquiry. 2024; 61:469580241254546.

PMID: 38779955 PMC: 11119532. DOI: 10.1177/00469580241254546.


Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.

Eustaquio P, Dela Cruz J, Arana Y, Rosos B, Rosadino J, Pagtakhan R BMJ Open. 2023; 13(9):e072252.

PMID: 37669846 PMC: 10481839. DOI: 10.1136/bmjopen-2023-072252.


The State of the HIV Epidemic in the Philippines: Progress and Challenges in 2023.

Gangcuangco L, Eustaquio P Trop Med Infect Dis. 2023; 8(5).

PMID: 37235306 PMC: 10224495. DOI: 10.3390/tropicalmed8050258.

References
1.
Melendez R, Exner T, Ehrhardt A, Dodge B, Remien R, Rotheram-Borus M . Health and health care among male-to-female transgender persons who are HIV positive. Am J Public Health. 2005; 96(6):1034-7. PMC: 1470610. DOI: 10.2105/AJPH.2004.042010. View

2.
Vasilenko S, Evans-Polce R, Lanza S . Age trends in rates of substance use disorders across ages 18-90: Differences by gender and race/ethnicity. Drug Alcohol Depend. 2017; 180:260-264. PMC: 5757874. DOI: 10.1016/j.drugalcdep.2017.08.027. View

3.
Day J, Perez-Brumer A, Russell S . Safe Schools? Transgender Youth's School Experiences and Perceptions of School Climate. J Youth Adolesc. 2018; 47(8):1731-1742. PMC: 7153781. DOI: 10.1007/s10964-018-0866-x. View

4.
Santos G, Wilson E, Rapues J, Macias O, Packer T, Raymond H . HIV treatment cascade among transgender women in a San Francisco respondent driven sampling study. Sex Transm Infect. 2014; 90(5):430-3. DOI: 10.1136/sextrans-2013-051342. View

5.
Bradford J, Reisner S, Honnold J, Xavier J . Experiences of transgender-related discrimination and implications for health: results from the Virginia Transgender Health Initiative Study. Am J Public Health. 2012; 103(10):1820-9. PMC: 3780721. DOI: 10.2105/AJPH.2012.300796. View